The Latest Breaking News from Cancer

This is what could happen next to Johnson & Johnson shares.

For the first time in 50 years, a phase 3 randomised, placebo-controlled trial found that an adjuvant therapy improved overall survival in kidney cancer patients. Read further on Dynamite News:

Johnson & Johnson wins trial over cancer claims related to baby powder in Florida. Company maintains product safety amidst ongoing legal battles.

Nationwide colorectal cancer incidence and mortality rates have fallen since 2000, but rates have been increasing among younger adults for several years.

BCCI hosts 12,000 cancer and thalassemia patients as special invitees at IPL match, raising awareness and providing entertainment.

He also revealed his youngest child Prince Louis’ favorite sport while at the engagement.

He returned to work today and reassured royal fans

The biotech sector is primed for growth, fueled by a surge in FDA approvals, anticipated M&A deals, and the integration of AI in drug discovery. So, fundamentally sound biotech stocks Theratechnologies (THTX), Harmony Biosciences (HRMY), and Shionogi & Co. (SGIOY) might be solid buys in this month. Keep reading.

William helps out at food distribution charity, Surplus to Supper, in Sunbury-on-Thames, Surrey, before a visit to a youth centre in west London

"I figured, as a woman, I can't escape menopause. So I'd rather just take it on now."

Prince William returns to public duties, supporting food waste reduction and addressing royal family's health challenges.